jc11 is a partially penetrant, maternal-effect cold-sensitive allele of the glycogen debranching enzyme gene
agl-1 (R06A4.8).
agl-1(
jc11) embryos arrest at various developmental stages including pre-morphogenesis, enclosure, and elongation. Successfully hatching animals occasionally have morphogenetic defects including tail and snout abnormalities.
agl-1(
jc11) is rescued by expression of R06A4.8::GFP and R06A4.8 RNAi phenocopies
agl-1(
jc11). In
agl-1(
jc11) animals, a four base pair deletion located in R06A4.8 is predicted to result in a frameshift and truncation of the debranching enzyme prior to the glycogen-binding domain.
agl-1(
jc11) is phenocopied by treatment with MOR-14 (N-Methyl-1-Deoxynojirimycin), an inhibitor that targets the ---1,6-glucosidase activity of glycogen-debranching enzyme. Overexpression of AGL-1::GFP results inincreased debranching activity based on reduced glycogen staining with carminic acid in both embryos and adults expressing AGL-1::GFP. Recently, the beta;1 subunit of the energy sensor AMP-activated kinase was shown to directly interact with glycogen debranching enzyme and strong binding of AMPK beta;1 to glycogen was shown to depend on the alpha;-1,6-branch; binding in turn functions to inhibit AMPK activity[1, 2]. Loss of
agl-1 function in C. elegans is predicted to result in the formation of a 'limit dextrin' glycogen molecule in which outer glucose chains are digested by phosphorylase to within four glucose residues of the alpha;-1-6 branch, resulting in a glycogen molecule well-suited to bind to and inhibit AMPK activity. Consistent with this model, over-expression of the glycogen-binding domain of AAKB-2 (an AMPK beta; subunit) suppresses
agl-1(
jc11) phenotypes. Also, in
agl-1(
jc11) mutants, AMPK activity is reduced; in turn, overexpression of
aak-2, which encodes the catalytic subunit of AMPK, suppresses
agl-1(
jc11) phenotypes.
agl-1(
jc11) animals that survive to adulthood have a shorter life span than wild type, similar to animals lacking AMPK activity, and preliminary results indicate that over-expression of
agl-1 increases lifespan. Finally, AGL-1 and AAKB-2 co-immunoprecipitate from worm extracts, suggesting that AGL-1 and AAKB-2 physically interact to regulate energy metabolism and lifespan via glycogen. 1.Sakoda, H., et al.,. Am J Physiol Endocrinol Metab, 2005. 289(3): p. E474-81. 2.McBride, A., et al., Cell Metab, 2009. 9(1): p. 23-34.